Seminars in Nuclear Medicine
Volume 32, Issue 2 , Pages 141-147, April 2002

Receptor-mediated radiotherapy with 90Y-DOTA-DPhe1-Tyr3-octreotide: The experience of the european institute of oncology group1

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

1 Supported by grants of the Italian association for Cancer Research (AIRC) and Consiglio Nazionale delle Ricerche (CNR-MIUR) PS Oncologia.

PII: S0001-2998(02)80032-0

doi:10.1053/snuc.2002.31563

Seminars in Nuclear Medicine
Volume 32, Issue 2 , Pages 141-147, April 2002

Article Tools